These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

162 related items for PubMed ID: 12576419

  • 1. Flavopiridol-related proinflammatory syndrome is associated with induction of interleukin-6.
    Messmann RA, Ullmann CD, Lahusen T, Kalehua A, Wasfy J, Melillo G, Ding I, Headlee D, Figg WD, Sausville EA, Senderowicz AM.
    Clin Cancer Res; 2003 Feb; 9(2):562-70. PubMed ID: 12576419
    [Abstract] [Full Text] [Related]

  • 2. Flavopiridol metabolism in cancer patients is associated with the occurrence of diarrhea.
    Innocenti F, Stadler WM, Iyer L, Ramírez J, Vokes EE, Ratain MJ.
    Clin Cancer Res; 2000 Sep; 6(9):3400-5. PubMed ID: 10999721
    [Abstract] [Full Text] [Related]

  • 3. Novel direct and indirect cyclin-dependent kinase modulators for the prevention and treatment of human neoplasms.
    Senderowicz AM.
    Cancer Chemother Pharmacol; 2003 Jul; 52 Suppl 1():S61-73. PubMed ID: 12819936
    [Abstract] [Full Text] [Related]

  • 4. Relation of pro- and anti-inflammatory cytokines and the production of nitric oxide in patients receiving high-dose immunotherapy with interleukin-2.
    Locker GJ, Kofler J, Stoiser B, Wilfing A, Wenzel C, Wögerbauer M, Steger GG, Zielinski CC, Mader R, Burgmann H.
    Eur Cytokine Netw; 2000 Sep; 11(3):391-6. PubMed ID: 11022123
    [Abstract] [Full Text] [Related]

  • 5. Clinical pharmacology of flavopiridol following a 72-hour continuous infusion.
    Rudek MA, Bauer KS, Lush RM, Stinson SF, Senderowicz AM, Headlee DJ, Arbuck SG, Cox MC, Murgo AJ, Sausville EA, Figg WD.
    Ann Pharmacother; 2003 Oct; 37(10):1369-74. PubMed ID: 14519054
    [Abstract] [Full Text] [Related]

  • 6. Phase I clinical and pharmacokinetic study of flavopiridol in children with refractory solid tumors: a Children's Oncology Group Study.
    Whitlock JA, Krailo M, Reid JM, Ruben SL, Ames MM, Owen W, Reaman G, Children's Oncology Group Study.
    J Clin Oncol; 2005 Dec 20; 23(36):9179-86. PubMed ID: 16361620
    [Abstract] [Full Text] [Related]

  • 7. Phase I and pharmacokinetic study of flavopiridol followed by 1-beta-D-arabinofuranosylcytosine and mitoxantrone in relapsed and refractory adult acute leukemias.
    Karp JE, Passaniti A, Gojo I, Kaufmann S, Bible K, Garimella TS, Greer J, Briel J, Smith BD, Gore SD, Tidwell ML, Ross DD, Wright JJ, Colevas AD, Bauer KS.
    Clin Cancer Res; 2005 Dec 01; 11(23):8403-12. PubMed ID: 16322302
    [Abstract] [Full Text] [Related]

  • 8. Phase I trial of continuous infusion flavopiridol, a novel cyclin-dependent kinase inhibitor, in patients with refractory neoplasms.
    Senderowicz AM, Headlee D, Stinson SF, Lush RM, Kalil N, Villalba L, Hill K, Steinberg SM, Figg WD, Tompkins A, Arbuck SG, Sausville EA.
    J Clin Oncol; 1998 Sep 01; 16(9):2986-99. PubMed ID: 9738567
    [Abstract] [Full Text] [Related]

  • 9. Systemic inflammatory response to exhaustive exercise. Cytokine kinetics.
    Suzuki K, Nakaji S, Yamada M, Totsuka M, Sato K, Sugawara K.
    Exerc Immunol Rev; 2002 Sep 01; 8():6-48. PubMed ID: 12690937
    [Abstract] [Full Text] [Related]

  • 10. Role of the kidney in plasma cytokine removal in sepsis syndrome: a pilot study.
    Graziani G, Bordone G, Bellato V, Finazzi S, Angelini C, Badalamenti S, Gruppo di Studio Trattamenti depurativi in area critica of the Italian Society of Nephrology.
    J Nephrol; 2006 Sep 01; 19(2):176-82. PubMed ID: 16736416
    [Abstract] [Full Text] [Related]

  • 11. Acute effect of hemodialysis on serum levels of the proinflammatory cytokines.
    Tarakçioğlu M, Erbağci AB, Usalan C, Deveci R, Kocabaş R.
    Mediators Inflamm; 2003 Feb 01; 12(1):15-9. PubMed ID: 12745544
    [Abstract] [Full Text] [Related]

  • 12. Phase I trial of the cyclin-dependent kinase inhibitor flavopiridol in combination with docetaxel in patients with metastatic breast cancer.
    Tan AR, Yang X, Berman A, Zhai S, Sparreboom A, Parr AL, Chow C, Brahim JS, Steinberg SM, Figg WD, Swain SM.
    Clin Cancer Res; 2004 Aug 01; 10(15):5038-47. PubMed ID: 15297405
    [Abstract] [Full Text] [Related]

  • 13. Hypercytokinemia and hyperactivation of phospho-p38 mitogen-activated protein kinase in severe human influenza A virus infection.
    Lee N, Wong CK, Chan PK, Lun SW, Lui G, Wong B, Hui DS, Lam CW, Cockram CS, Choi KW, Yeung AC, Tang JW, Sung JJ.
    Clin Infect Dis; 2007 Sep 15; 45(6):723-31. PubMed ID: 17712756
    [Abstract] [Full Text] [Related]

  • 14. Prognostic significance of blood markers of inflammation in patients with ST-segment elevation myocardial infarction undergoing primary angioplasty and effects of pexelizumab, a C5 inhibitor: a substudy of the COMMA trial.
    Théroux P, Armstrong PW, Mahaffey KW, Hochman JS, Malloy KJ, Rollins S, Nicolau JC, Lavoie J, Luong TM, Burchenal J, Granger CB.
    Eur Heart J; 2005 Oct 15; 26(19):1964-70. PubMed ID: 15872036
    [Abstract] [Full Text] [Related]

  • 15. Clinical trials referral resource. Clinical trials of flavopiridol.
    Wright J, Blatner GL, Cheson BD.
    Oncology (Williston Park); 1998 Jul 15; 12(7):1018, 1023-4. PubMed ID: 9684276
    [No Abstract] [Full Text] [Related]

  • 16. A phase II study of flavopiridol in patients with advanced renal cell carcinoma: results of Southwest Oncology Group Trial 0109.
    Van Veldhuizen PJ, Faulkner JR, Lara PN, Gumerlock PH, Goodwin JW, Dakhil SR, Gross HM, Flanigan RC, Crawford ED, Southwest Oncology Group.
    Cancer Chemother Pharmacol; 2005 Jul 15; 56(1):39-45. PubMed ID: 15791454
    [Abstract] [Full Text] [Related]

  • 17. Phase I trial of a novel diphtheria toxin/granulocyte macrophage colony-stimulating factor fusion protein (DT388GMCSF) for refractory or relapsed acute myeloid leukemia.
    Frankel AE, Powell BL, Hall PD, Case LD, Kreitman RJ.
    Clin Cancer Res; 2002 May 15; 8(5):1004-13. PubMed ID: 12006512
    [Abstract] [Full Text] [Related]

  • 18. Phase I clinical and pharmacokinetic study of flavopiridol administered as a daily 1-hour infusion in patients with advanced neoplasms.
    Tan AR, Headlee D, Messmann R, Sausville EA, Arbuck SG, Murgo AJ, Melillo G, Zhai S, Figg WD, Swain SM, Senderowicz AM.
    J Clin Oncol; 2002 Oct 01; 20(19):4074-82. PubMed ID: 12351605
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.